Tuberculosis Archives - Regulatory Professionals

July 3, 2012

Tuberculosis Drug, Bedaquiline, Submitted for FDA New Drug Application Approval

Johnson & Johnson’s Janssen Research & Development unit yesterday announced that they have filed a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for bedaquiline, in the hope that it will be the first drug with a new mechanism of action for tuberculosis (TB) in over 40 years. Specifically, Janssen is

Written by Stephen Smith

October 12, 2011

BMS Foundation Announces Collaboration with WHO Stop TB Department

The Bristol-Myers Squibb Foundation yesterday announced a partnership with the World Health Organization’s (WHO) Stop TB Department for a two-year pilot initiative to strengthen community based prevention, care and control of tuberculosis (TB) including co-infection with HIV in South Africa, Tanzania, Kenya, Ethiopia and Democratic Republic of the Congo. These countries represented more than 13%

Regulatory Professionals

Regulatory Affairs Recruitment

Tuberculosis

Tuberculosis Drug, Bedaquiline, Submitted for FDA New Drug Application Approval

BMS Foundation Announces Collaboration with WHO Stop TB Department

Like to Talk to a Consultant?